Skip to main content
Clinical Trials/JPRN-UMIN000044579
JPRN-UMIN000044579
Completed
未知

A multicenter prospective observational study to explore biomarkers of anti PD-1 antibody therapy for gastric cancer - A multicenter prospective observational study to explore biomarkers of anti PD-1 antibody therapy for gastric cancer

Keio University Hospital Department of Internal Medicine, Division of Gastroenterology and Hepatology0 sites50 target enrollmentJune 17, 2021
ConditionsGastric cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Gastric cancer
Sponsor
Keio University Hospital Department of Internal Medicine, Division of Gastroenterology and Hepatology
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 17, 2021
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Keio University Hospital Department of Internal Medicine, Division of Gastroenterology and Hepatology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Patients with active multiple cancers (concurrent multiple cancers/multiple cancers and heterogeneous multiple cancers/multiple cancers with disease\-free interval of 3 years or less. (However, if the cancer is not a prognostic factor for the patient, it is not excluded.) (2\) Patients with psychosis or psychiatric symptoms that interfere with daily life, making it difficult to participate in the study. 3\) Other conditions deemed inappropriate by the physician in charge.

Outcomes

Primary Outcomes

Not specified

Similar Trials